Bianchi, Antonio
 Distribuzione geografica
Continente #
EU - Europa 2.822
NA - Nord America 2.612
AS - Asia 912
SA - Sud America 14
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 1
Totale 6.380
Nazione #
US - Stati Uniti d'America 2.597
DE - Germania 949
SE - Svezia 462
IT - Italia 394
CN - Cina 368
SG - Singapore 317
UA - Ucraina 235
PL - Polonia 209
IE - Irlanda 150
FR - Francia 109
ID - Indonesia 103
FI - Finlandia 83
RU - Federazione Russa 75
GB - Regno Unito 73
IN - India 43
BE - Belgio 27
JP - Giappone 18
IR - Iran 17
TR - Turchia 17
CA - Canada 15
NL - Olanda 13
VN - Vietnam 11
CI - Costa d'Avorio 10
HK - Hong Kong 9
CH - Svizzera 7
CZ - Repubblica Ceca 6
RO - Romania 6
CO - Colombia 5
ES - Italia 5
BR - Brasile 4
PT - Portogallo 4
A2 - ???statistics.table.value.countryCode.A2??? 3
EU - Europa 3
IL - Israele 3
LT - Lituania 3
CL - Cile 2
KR - Corea 2
MD - Moldavia 2
PE - Perù 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
AT - Austria 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
EG - Egitto 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IQ - Iraq 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MA - Marocco 1
NO - Norvegia 1
RS - Serbia 1
SC - Seychelles 1
Totale 6.380
Città #
Chandler 602
Singapore 251
Warsaw 195
Ashburn 176
Dublin 139
San Mateo 126
Ann Arbor 111
New York 110
Jakarta 100
Jacksonville 95
Fairfield 93
Wilmington 90
Rome 76
Nanjing 68
Boston 64
Marseille 59
Milan 56
Seattle 51
Woodbridge 50
Moscow 49
Princeton 48
Bremen 47
Nürnberg 46
Houston 44
Helsinki 43
Cattolica 41
Dearborn 35
Zhengzhou 31
Los Angeles 30
Beijing 28
Munich 28
Redwood City 28
Boardman 27
Lawrence 27
Cambridge 26
Brussels 25
Nanchang 25
Chicago 23
Mountain View 23
University Park 21
Norwalk 19
Hangzhou 17
Shenyang 16
Hebei 13
Kraków 13
Redmond 13
Shanghai 13
Augusta 12
Kunming 12
Leawood 12
Fremont 11
Izmir 11
Abidjan 10
Guangzhou 10
Kish 10
Tianjin 10
Changsha 9
Hong Kong 9
London 9
Falkenstein 8
Pune 8
Santa Clara 8
Washington 8
Brescia 7
Hanoi 7
Jiaxing 7
Lancaster 7
Mumbai 7
Paris 7
Piacenza 7
Simi Valley 7
Detroit 6
Frankfurt am Main 6
Jinan 6
Ferrara 5
Menlo Park 5
Nuremberg 5
Renton 5
Toronto 5
Andover 4
Brno 4
Campobasso 4
Dong Ket 4
Edinburgh 4
Ningbo 4
Ottawa 4
Sakaemachi 4
Tokyo 4
West Jordan 4
Amsterdam 3
Ardea 3
Bandung 3
Bari 3
Bergamo 3
Busto Arsizio 3
Castignano 3
Cedar Crest 3
Dalmine 3
Fuzhou 3
Gunzenhausen 3
Totale 3.640
Nome #
Increased FGF23 serum level is associated with unstable carotid plaque in type 2 diabetic subjects with internal carotid stenosis. 351
Hypophysitis Outcome and Factors Predicting Responsiveness to Glucocorticoid Therapy: A Prospective and Double-Arm Study. 236
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 233
Double pituitary adenomas 193
Predictors of morbidity and mortality in acromegaly, an Italian survey. 187
Coenzyme Q10 evaluation in pituitary-adrenal axis disease: preliminary data. 149
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 149
Typical and Atypical Pituitary Adenomas: A Single-Center Analysis of Outcome and Prognosis 141
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 140
Effects of gherlin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 133
An Overview of Diagnosis of Primary Autoimmune Hypophysitis in a Single Prospective Monocentric Experience 130
Increased estradiol levels in venous occlusive disorder: a possible functional mechanism of venous leakage. 127
Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study 108
Hypothalamitis: a diagnostic and therapeutic challenge 107
Influence of diabetes mellitus on vertebral fractures in men with acromegaly 104
Radically resected pituitary adenomas: prognostic role of Ki67 labeling index in monocentric retrospective series and literature review 101
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 100
Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes 97
The effect of treatment with growth hormone on fertility outcome in eugonadal women with growth hormone deficiency: report of four cases and review of the literature 96
Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency 94
Significant GH-deficiency after long-term cure by surgery in adult patients with Cushing s disease 92
The Changing Clinical Spectrum of Hypophysitis 91
Hypopituitarism findings in patients with primary brain tumors 1 year after neurosurgical treatment: preliminary report. 86
Pasireotide and Pegvisomant Combination Treatment in Acromegaly Resistant to Second Line Therapies: A Longitudinal Study 86
GH receptor isoforms and skeletal fragility in acromegaly 84
Hormonal and metabolic evaluation in Down's syndrome: preliminary evidence for TSH dysregulation in hyperthyrotropinemic patients 83
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response 81
DIAGNOSIS OF ENDOCRINE DISEASE: Primary Empty Sella: a comprehensive review 77
Risk factors for pancreas and lung neuroendocrine neoplasms: a case–control study 74
High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas 71
Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency 71
Spontaneous thyroid nodule hemorrhage in the emergency department 70
Gene expression profiling of pancreas neuroendocrine tumors with different ki67‐based grades 69
Nonthyroidal illness syndrome and prolonged mechanical ventilation in patients admitted to the ICU. 68
Synchronous Bilateral Adrenalectomy in ACTH-dependent Hypercortisolism: Predictors, Biomarkers and Outcomes 68
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study. 67
The exon 3-deleted growth hormone receptor: Molecular and functional characterization and impact on GH/IGF-I axis in physiological and pathological conditions 66
Vertebral fractures in patients with acromegaly: a 3-year prospective study 63
Clinical management of teratoma, a rare hypothalamic-pituitary neoplasia 63
Human leucocyte antigens coeliac haplotypes and primary autoimmune hypophysitis in caucasian patients 60
Effects of thyroid hormone treatment on diaphragmatic efficiency in mechanically ventilated subjects with nonthyroidal illness syndrome 60
The changing clinical spectrum of endocrine adverse events in cancer immunotherapy 60
Empty sella syndrome: Multiple endocrine disorders. 59
Systemic mastocytosis mimicking carcinoid syndrome 58
Neuro-radiological features can predict hypopituitarism in primary autoimmune hypophysitis 58
Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. 57
Long-term effects of the combination of pegvisomant with somatostatin analogs (SSA) on glucose homeostasis in non-diabetic patients with active acromegaly partially resistant to SSA 57
Reappraising the Role of Trans-Sphenoidal Surgery in Prolactin-Secreting Pituitary Tumors. 57
Vertebral fractures in males with prolactinoma. 55
Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot Study 55
The Role of Growth Hormone Receptor Isoforms and Their Effects in Bone Metabolism and Skeletal Fragility 54
High prevalence of hyperplastic colonic polyps in acromegalic subjects. 53
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 52
Growth hormone receptor isoforms and fracture risk in adult-onset growth hormone-deficient patients. 52
Proteomics of Pancreatic Neuroendocrine Tumors: A Systematic Review 52
Short- and long-term responsiveness to low dose growth hormone (GH) in adult GH deficiency: Role of GH receptor polymorphism. 51
Understanding the effect of acromegaly on the human skeleton. 51
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 51
Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly. 49
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome. 49
Autoantibody reactivity profile of primary autoimmune hypophysitis patients: preliminary results 49
Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study. 47
Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study 47
Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs. 47
Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant 46
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion. 45
Microalbuminuria in insulin sensitivity in patients with growth hormone-secreting pituitary tumor. 44
Prevalence of morphometric vertebral fractures in "difficult" patients with acromegaly with different biochemical outcomes after multimodal treatment. 44
Acromegaly can be cured by first-line pasireotide treatment? 42
Hypothalamitis and pituitary atrophy 42
Nonthyroidal illness syndrome and prolonged mechanical ventilation in patients admitted to the ICU 41
Acromegaly in the elderly patients 38
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin? 37
Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. 37
Treatment of Acromegalic Osteopathy in Real-life Clinical Practice: The BAAC (Bone Active Drugs in Acromegaly) Study 36
Pediatric craniopharyngiomas: magnetic resonance imaging assessment for hypothalamus-pituitary axis dysfunction and outcome prediction 33
Competitive testing of the WHO 2010 versus the WHO 2017 grading of pancreatic neuroendocrine neoplasms: Data from a large international cohort study 33
Diabetic neuropathy: a risk factor for severe COVID-19? 28
Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues 25
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience 24
Systemic comorbidities of acromegaly in real-life experience: which difference among young and elderly patients? 23
The Pathogenic RET Val804Met Variant in Acromegaly: A New Clinical Phenotype? 23
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 16
Unveiling the Etiopathogenic Spectrum of Hypophysitis: A Narrative Review 15
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience 15
The multi-biomarker acro-TIME score predicts fg-SRLs response: preliminary results of a retrospective acromegaly cohort 13
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways 13
CD68+ and CD8+ immune cells are associated with the growth pattern of somatotroph tumors and response to first generation somatostatin analogs 12
Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors 11
Trouillas’s Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach 10
De-escalation treatment with pasireotide for acromegaly: a long-term experience 10
Letter: A Multicenter, Propensity Score- Matched Assessment of Endoscopic Versus Microscopic Approaches in the Management of Pituitary Adenomas 10
Trouillas's Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach 9
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience 8
Markers of humoral and cell-mediated immune response in primary autoimmune hypophysitis: a pilot study 7
Cholecalciferol Use Is Associated With a Decreased Risk of Incident Morphometric Vertebral Fractures in Acromegaly 7
Regression of EI2-stage low-grade gastric MALT-lymphoma after H. Pylori eradication 6
Use of 111In-pentetreotide scintigraphy for diagnosis and management of resistant macroprolactinoma 6
Second line treatment of acromegaly: Pasireotide or Pegvisomant? 5
Two diagnostic pitfalls mimicking a prolactin-secreting microadenoma 4
Totale 6.564
Categoria #
all - tutte 30.645
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.645


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020467 0 0 0 0 0 65 147 50 44 36 74 51
2020/2021530 30 57 14 53 65 31 60 13 57 47 92 11
2021/2022753 27 44 9 70 87 33 19 129 26 44 108 157
2022/20231.681 191 225 138 267 99 230 96 140 178 16 63 38
2023/2024879 33 203 32 42 42 144 44 19 31 53 102 134
2024/2025561 44 50 157 95 137 78 0 0 0 0 0 0
Totale 6.568